AKESOgen Competitors and Similar CompaniesClear all

AKESOgen's competitors and similar companies include Akebia Therapeutics and F-star Biotechnology.
AKESOgen
AKESOgen
AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural
Akebia Therapeutics
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
F-star Biotechnology
F-star Biotechnology
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
Founding Date
Founding Date
2010
Founding Date
2007
Founding Date
2006
Type
Type
Subsidiary
Type
Public
Type
Private
Tags
Locations
Locations
Norcross, US HQ
Locations
Cambridge, US HQ
Locations
Cambridge, GB HQ
Wien, AT
Cambridge, US
Employees
Employees
6
Employees
324187% increase
Employees
39

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$236.2m (FY, 2025)
Revenue (est.)
£18.7m (FY, 2018)
Net income
Net income
N/A
Net income
($5.3m) (FY, 2025)
Net income
(£2.6m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 1.5m
Total funding raised
N/A
Total funding raised
$ 57.3m
For sources of this data, please see the company profile

View Company Profiles

Akebia Therapeutics
HQ
Cambridge, US
Employees
324

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

View company
F-star Biotechnology
HQ
Cambridge, GB
Employees
39

F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

View company